Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
3.810
0.00 (0.00%)
Oct 8, 2026, 12:05 PM EDT - Market open
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $153.02 million as of October 8, 2026. Its market cap has increased by 9.85% in one year.
Market Cap
153.02M
Enterprise Value
75.18M
1-Year Change
9.85%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $153.02M, a decrease of -77.61%. That is a compound annual growth rate of -24.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 153.02M | -4.44% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -7.89% |
| Jun 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 162.82M |
| NovaBridge Biosciences | 162.40M |
| Coherus Oncology | 162.23M |
| ALX Oncology Holdings | 156.94M |
| Protara Therapeutics | 156.60M |
| Acumen Pharmaceuticals | 155.48M |
| Codexis | 154.40M |
| Korro Bio | 153.59M |